Global Invasive Candidiasis Treatment Drug Market Growth (Status and Outlook) 2026-2032
The global Invasive Candidiasis Treatment Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for Invasive Candidiasis Treatment Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Invasive Candidiasis Treatment Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Invasive Candidiasis Treatment Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Invasive Candidiasis Treatment Drug players cover GlaxoSmithKline, Merck & Co., Inc, Pfizer Inc, Cidara Therapeutics, Inc, Astellas Pharma Inc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Invasive Candidiasis Treatment Drug Industry Forecast” looks at past sales and reviews total world Invasive Candidiasis Treatment Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected Invasive Candidiasis Treatment Drug sales for 2026 through 2032. With Invasive Candidiasis Treatment Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Invasive Candidiasis Treatment Drug industry.
This Insight Report provides a comprehensive analysis of the global Invasive Candidiasis Treatment Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Invasive Candidiasis Treatment Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Invasive Candidiasis Treatment Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Invasive Candidiasis Treatment Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Invasive Candidiasis Treatment Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Invasive Candidiasis Treatment Drug market by product type, application, key players and key regions and countries.
Segmentation by Type:
United States market for Invasive Candidiasis Treatment Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Invasive Candidiasis Treatment Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Invasive Candidiasis Treatment Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Invasive Candidiasis Treatment Drug players cover GlaxoSmithKline, Merck & Co., Inc, Pfizer Inc, Cidara Therapeutics, Inc, Astellas Pharma Inc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Invasive Candidiasis Treatment Drug Industry Forecast” looks at past sales and reviews total world Invasive Candidiasis Treatment Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected Invasive Candidiasis Treatment Drug sales for 2026 through 2032. With Invasive Candidiasis Treatment Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Invasive Candidiasis Treatment Drug industry.
This Insight Report provides a comprehensive analysis of the global Invasive Candidiasis Treatment Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Invasive Candidiasis Treatment Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Invasive Candidiasis Treatment Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Invasive Candidiasis Treatment Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Invasive Candidiasis Treatment Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Invasive Candidiasis Treatment Drug market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Azoles Drug
- Echinocandins Drug
- Allylamines Drug
- Polyenes Drug
- Others
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GlaxoSmithKline
- Merck & Co., Inc
- Pfizer Inc
- Cidara Therapeutics, Inc
- Astellas Pharma Inc
- Gilead Sciences, Inc
- Novo Nordisk A/S (Xellia Pharmaceuticals)
- Biosergen AB
- Matinas BioPharma Holdings, Inc
- Pulmocide Ltd
- F2G Ltd
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Invasive Candidiasis Treatment Drug Market Size (2021-2032)
2.1.2 Invasive Candidiasis Treatment Drug Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Invasive Candidiasis Treatment Drug by Country/Region (2021, 2025 & 2032)
2.2 Invasive Candidiasis Treatment Drug Segment by Type
2.2.1 Azoles Drug
2.2.2 Echinocandins Drug
2.2.3 Allylamines Drug
2.2.4 Polyenes Drug
2.2.5 Others
2.2.6 Invasive Candidiasis Treatment Drug Market Size by Type
2.2.6.1 Invasive Candidiasis Treatment Drug Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.6.2 Global Invasive Candidiasis Treatment Drug Market Size Market Share by Type (2021-2026)
2.3 Invasive Candidiasis Treatment Drug Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Others
2.3.4 Invasive Candidiasis Treatment Drug Market Size by Application
2.3.4.1 Invasive Candidiasis Treatment Drug Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Invasive Candidiasis Treatment Drug Market Size Market Share by Application (2021-2026)
3 INVASIVE CANDIDIASIS TREATMENT DRUG MARKET SIZE BY PLAYER
3.1 Invasive Candidiasis Treatment Drug Market Size Market Share by Player
3.1.1 Global Invasive Candidiasis Treatment Drug Revenue by Player (2021-2026)
3.1.2 Global Invasive Candidiasis Treatment Drug Revenue Market Share by Player (2021-2026)
3.2 Global Invasive Candidiasis Treatment Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 INVASIVE CANDIDIASIS TREATMENT DRUG BY REGION
4.1 Invasive Candidiasis Treatment Drug Market Size by Region (2021-2026)
4.2 Global Invasive Candidiasis Treatment Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas Invasive Candidiasis Treatment Drug Market Size Growth (2021-2026)
4.4 APAC Invasive Candidiasis Treatment Drug Market Size Growth (2021-2026)
4.5 Europe Invasive Candidiasis Treatment Drug Market Size Growth (2021-2026)
4.6 Middle East & Africa Invasive Candidiasis Treatment Drug Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Invasive Candidiasis Treatment Drug Market Size by Country (2021-2026)
5.2 Americas Invasive Candidiasis Treatment Drug Market Size by Type (2021-2026)
5.3 Americas Invasive Candidiasis Treatment Drug Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Invasive Candidiasis Treatment Drug Market Size by Region (2021-2026)
6.2 APAC Invasive Candidiasis Treatment Drug Market Size by Type (2021-2026)
6.3 APAC Invasive Candidiasis Treatment Drug Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Invasive Candidiasis Treatment Drug Market Size by Country (2021-2026)
7.2 Europe Invasive Candidiasis Treatment Drug Market Size by Type (2021-2026)
7.3 Europe Invasive Candidiasis Treatment Drug Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Invasive Candidiasis Treatment Drug by Region (2021-2026)
8.2 Middle East & Africa Invasive Candidiasis Treatment Drug Market Size by Type (2021-2026)
8.3 Middle East & Africa Invasive Candidiasis Treatment Drug Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL INVASIVE CANDIDIASIS TREATMENT DRUG MARKET FORECAST
10.1 Global Invasive Candidiasis Treatment Drug Forecast by Region (2027-2032)
10.1.1 Global Invasive Candidiasis Treatment Drug Forecast by Region (2027-2032)
10.1.2 Americas Invasive Candidiasis Treatment Drug Forecast
10.1.3 APAC Invasive Candidiasis Treatment Drug Forecast
10.1.4 Europe Invasive Candidiasis Treatment Drug Forecast
10.1.5 Middle East & Africa Invasive Candidiasis Treatment Drug Forecast
10.2 Americas Invasive Candidiasis Treatment Drug Forecast by Country (2027-2032)
10.2.1 United States Market Invasive Candidiasis Treatment Drug Forecast
10.2.2 Canada Market Invasive Candidiasis Treatment Drug Forecast
10.2.3 Mexico Market Invasive Candidiasis Treatment Drug Forecast
10.2.4 Brazil Market Invasive Candidiasis Treatment Drug Forecast
10.3 APAC Invasive Candidiasis Treatment Drug Forecast by Region (2027-2032)
10.3.1 China Invasive Candidiasis Treatment Drug Market Forecast
10.3.2 Japan Market Invasive Candidiasis Treatment Drug Forecast
10.3.3 Korea Market Invasive Candidiasis Treatment Drug Forecast
10.3.4 Southeast Asia Market Invasive Candidiasis Treatment Drug Forecast
10.3.5 India Market Invasive Candidiasis Treatment Drug Forecast
10.3.6 Australia Market Invasive Candidiasis Treatment Drug Forecast
10.4 Europe Invasive Candidiasis Treatment Drug Forecast by Country (2027-2032)
10.4.1 Germany Market Invasive Candidiasis Treatment Drug Forecast
10.4.2 France Market Invasive Candidiasis Treatment Drug Forecast
10.4.3 UK Market Invasive Candidiasis Treatment Drug Forecast
10.4.4 Italy Market Invasive Candidiasis Treatment Drug Forecast
10.4.5 Russia Market Invasive Candidiasis Treatment Drug Forecast
10.5 Middle East & Africa Invasive Candidiasis Treatment Drug Forecast by Region (2027-2032)
10.5.1 Egypt Market Invasive Candidiasis Treatment Drug Forecast
10.5.2 South Africa Market Invasive Candidiasis Treatment Drug Forecast
10.5.3 Israel Market Invasive Candidiasis Treatment Drug Forecast
10.5.4 Turkey Market Invasive Candidiasis Treatment Drug Forecast
10.6 Global Invasive Candidiasis Treatment Drug Forecast by Type (2027-2032)
10.7 Global Invasive Candidiasis Treatment Drug Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Invasive Candidiasis Treatment Drug Forecast
11 KEY PLAYERS ANALYSIS
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Information
11.1.2 GlaxoSmithKline Invasive Candidiasis Treatment Drug Product Offered
11.1.3 GlaxoSmithKline Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 GlaxoSmithKline Main Business Overview
11.1.5 GlaxoSmithKline Latest Developments
11.2 Merck & Co., Inc
11.2.1 Merck & Co., Inc Company Information
11.2.2 Merck & Co., Inc Invasive Candidiasis Treatment Drug Product Offered
11.2.3 Merck & Co., Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Merck & Co., Inc Main Business Overview
11.2.5 Merck & Co., Inc Latest Developments
11.3 Pfizer Inc
11.3.1 Pfizer Inc Company Information
11.3.2 Pfizer Inc Invasive Candidiasis Treatment Drug Product Offered
11.3.3 Pfizer Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Pfizer Inc Main Business Overview
11.3.5 Pfizer Inc Latest Developments
11.4 Cidara Therapeutics, Inc
11.4.1 Cidara Therapeutics, Inc Company Information
11.4.2 Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Product Offered
11.4.3 Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Cidara Therapeutics, Inc Main Business Overview
11.4.5 Cidara Therapeutics, Inc Latest Developments
11.5 Astellas Pharma Inc
11.5.1 Astellas Pharma Inc Company Information
11.5.2 Astellas Pharma Inc Invasive Candidiasis Treatment Drug Product Offered
11.5.3 Astellas Pharma Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Astellas Pharma Inc Main Business Overview
11.5.5 Astellas Pharma Inc Latest Developments
11.6 Gilead Sciences, Inc
11.6.1 Gilead Sciences, Inc Company Information
11.6.2 Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Product Offered
11.6.3 Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Gilead Sciences, Inc Main Business Overview
11.6.5 Gilead Sciences, Inc Latest Developments
11.7 Novo Nordisk A/S (Xellia Pharmaceuticals)
11.7.1 Novo Nordisk A/S (Xellia Pharmaceuticals) Company Information
11.7.2 Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Product Offered
11.7.3 Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Novo Nordisk A/S (Xellia Pharmaceuticals) Main Business Overview
11.7.5 Novo Nordisk A/S (Xellia Pharmaceuticals) Latest Developments
11.8 Biosergen AB
11.8.1 Biosergen AB Company Information
11.8.2 Biosergen AB Invasive Candidiasis Treatment Drug Product Offered
11.8.3 Biosergen AB Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Biosergen AB Main Business Overview
11.8.5 Biosergen AB Latest Developments
11.9 Matinas BioPharma Holdings, Inc
11.9.1 Matinas BioPharma Holdings, Inc Company Information
11.9.2 Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Product Offered
11.9.3 Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Matinas BioPharma Holdings, Inc Main Business Overview
11.9.5 Matinas BioPharma Holdings, Inc Latest Developments
11.10 Pulmocide Ltd
11.10.1 Pulmocide Ltd Company Information
11.10.2 Pulmocide Ltd Invasive Candidiasis Treatment Drug Product Offered
11.10.3 Pulmocide Ltd Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Pulmocide Ltd Main Business Overview
11.10.5 Pulmocide Ltd Latest Developments
11.11 F2G Ltd
11.11.1 F2G Ltd Company Information
11.11.2 F2G Ltd Invasive Candidiasis Treatment Drug Product Offered
11.11.3 F2G Ltd Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 F2G Ltd Main Business Overview
11.11.5 F2G Ltd Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Invasive Candidiasis Treatment Drug Market Size (2021-2032)
2.1.2 Invasive Candidiasis Treatment Drug Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Invasive Candidiasis Treatment Drug by Country/Region (2021, 2025 & 2032)
2.2 Invasive Candidiasis Treatment Drug Segment by Type
2.2.1 Azoles Drug
2.2.2 Echinocandins Drug
2.2.3 Allylamines Drug
2.2.4 Polyenes Drug
2.2.5 Others
2.2.6 Invasive Candidiasis Treatment Drug Market Size by Type
2.2.6.1 Invasive Candidiasis Treatment Drug Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.6.2 Global Invasive Candidiasis Treatment Drug Market Size Market Share by Type (2021-2026)
2.3 Invasive Candidiasis Treatment Drug Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Others
2.3.4 Invasive Candidiasis Treatment Drug Market Size by Application
2.3.4.1 Invasive Candidiasis Treatment Drug Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Invasive Candidiasis Treatment Drug Market Size Market Share by Application (2021-2026)
3 INVASIVE CANDIDIASIS TREATMENT DRUG MARKET SIZE BY PLAYER
3.1 Invasive Candidiasis Treatment Drug Market Size Market Share by Player
3.1.1 Global Invasive Candidiasis Treatment Drug Revenue by Player (2021-2026)
3.1.2 Global Invasive Candidiasis Treatment Drug Revenue Market Share by Player (2021-2026)
3.2 Global Invasive Candidiasis Treatment Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 INVASIVE CANDIDIASIS TREATMENT DRUG BY REGION
4.1 Invasive Candidiasis Treatment Drug Market Size by Region (2021-2026)
4.2 Global Invasive Candidiasis Treatment Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas Invasive Candidiasis Treatment Drug Market Size Growth (2021-2026)
4.4 APAC Invasive Candidiasis Treatment Drug Market Size Growth (2021-2026)
4.5 Europe Invasive Candidiasis Treatment Drug Market Size Growth (2021-2026)
4.6 Middle East & Africa Invasive Candidiasis Treatment Drug Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Invasive Candidiasis Treatment Drug Market Size by Country (2021-2026)
5.2 Americas Invasive Candidiasis Treatment Drug Market Size by Type (2021-2026)
5.3 Americas Invasive Candidiasis Treatment Drug Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Invasive Candidiasis Treatment Drug Market Size by Region (2021-2026)
6.2 APAC Invasive Candidiasis Treatment Drug Market Size by Type (2021-2026)
6.3 APAC Invasive Candidiasis Treatment Drug Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Invasive Candidiasis Treatment Drug Market Size by Country (2021-2026)
7.2 Europe Invasive Candidiasis Treatment Drug Market Size by Type (2021-2026)
7.3 Europe Invasive Candidiasis Treatment Drug Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Invasive Candidiasis Treatment Drug by Region (2021-2026)
8.2 Middle East & Africa Invasive Candidiasis Treatment Drug Market Size by Type (2021-2026)
8.3 Middle East & Africa Invasive Candidiasis Treatment Drug Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL INVASIVE CANDIDIASIS TREATMENT DRUG MARKET FORECAST
10.1 Global Invasive Candidiasis Treatment Drug Forecast by Region (2027-2032)
10.1.1 Global Invasive Candidiasis Treatment Drug Forecast by Region (2027-2032)
10.1.2 Americas Invasive Candidiasis Treatment Drug Forecast
10.1.3 APAC Invasive Candidiasis Treatment Drug Forecast
10.1.4 Europe Invasive Candidiasis Treatment Drug Forecast
10.1.5 Middle East & Africa Invasive Candidiasis Treatment Drug Forecast
10.2 Americas Invasive Candidiasis Treatment Drug Forecast by Country (2027-2032)
10.2.1 United States Market Invasive Candidiasis Treatment Drug Forecast
10.2.2 Canada Market Invasive Candidiasis Treatment Drug Forecast
10.2.3 Mexico Market Invasive Candidiasis Treatment Drug Forecast
10.2.4 Brazil Market Invasive Candidiasis Treatment Drug Forecast
10.3 APAC Invasive Candidiasis Treatment Drug Forecast by Region (2027-2032)
10.3.1 China Invasive Candidiasis Treatment Drug Market Forecast
10.3.2 Japan Market Invasive Candidiasis Treatment Drug Forecast
10.3.3 Korea Market Invasive Candidiasis Treatment Drug Forecast
10.3.4 Southeast Asia Market Invasive Candidiasis Treatment Drug Forecast
10.3.5 India Market Invasive Candidiasis Treatment Drug Forecast
10.3.6 Australia Market Invasive Candidiasis Treatment Drug Forecast
10.4 Europe Invasive Candidiasis Treatment Drug Forecast by Country (2027-2032)
10.4.1 Germany Market Invasive Candidiasis Treatment Drug Forecast
10.4.2 France Market Invasive Candidiasis Treatment Drug Forecast
10.4.3 UK Market Invasive Candidiasis Treatment Drug Forecast
10.4.4 Italy Market Invasive Candidiasis Treatment Drug Forecast
10.4.5 Russia Market Invasive Candidiasis Treatment Drug Forecast
10.5 Middle East & Africa Invasive Candidiasis Treatment Drug Forecast by Region (2027-2032)
10.5.1 Egypt Market Invasive Candidiasis Treatment Drug Forecast
10.5.2 South Africa Market Invasive Candidiasis Treatment Drug Forecast
10.5.3 Israel Market Invasive Candidiasis Treatment Drug Forecast
10.5.4 Turkey Market Invasive Candidiasis Treatment Drug Forecast
10.6 Global Invasive Candidiasis Treatment Drug Forecast by Type (2027-2032)
10.7 Global Invasive Candidiasis Treatment Drug Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Invasive Candidiasis Treatment Drug Forecast
11 KEY PLAYERS ANALYSIS
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Information
11.1.2 GlaxoSmithKline Invasive Candidiasis Treatment Drug Product Offered
11.1.3 GlaxoSmithKline Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 GlaxoSmithKline Main Business Overview
11.1.5 GlaxoSmithKline Latest Developments
11.2 Merck & Co., Inc
11.2.1 Merck & Co., Inc Company Information
11.2.2 Merck & Co., Inc Invasive Candidiasis Treatment Drug Product Offered
11.2.3 Merck & Co., Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Merck & Co., Inc Main Business Overview
11.2.5 Merck & Co., Inc Latest Developments
11.3 Pfizer Inc
11.3.1 Pfizer Inc Company Information
11.3.2 Pfizer Inc Invasive Candidiasis Treatment Drug Product Offered
11.3.3 Pfizer Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Pfizer Inc Main Business Overview
11.3.5 Pfizer Inc Latest Developments
11.4 Cidara Therapeutics, Inc
11.4.1 Cidara Therapeutics, Inc Company Information
11.4.2 Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Product Offered
11.4.3 Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Cidara Therapeutics, Inc Main Business Overview
11.4.5 Cidara Therapeutics, Inc Latest Developments
11.5 Astellas Pharma Inc
11.5.1 Astellas Pharma Inc Company Information
11.5.2 Astellas Pharma Inc Invasive Candidiasis Treatment Drug Product Offered
11.5.3 Astellas Pharma Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Astellas Pharma Inc Main Business Overview
11.5.5 Astellas Pharma Inc Latest Developments
11.6 Gilead Sciences, Inc
11.6.1 Gilead Sciences, Inc Company Information
11.6.2 Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Product Offered
11.6.3 Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Gilead Sciences, Inc Main Business Overview
11.6.5 Gilead Sciences, Inc Latest Developments
11.7 Novo Nordisk A/S (Xellia Pharmaceuticals)
11.7.1 Novo Nordisk A/S (Xellia Pharmaceuticals) Company Information
11.7.2 Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Product Offered
11.7.3 Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Novo Nordisk A/S (Xellia Pharmaceuticals) Main Business Overview
11.7.5 Novo Nordisk A/S (Xellia Pharmaceuticals) Latest Developments
11.8 Biosergen AB
11.8.1 Biosergen AB Company Information
11.8.2 Biosergen AB Invasive Candidiasis Treatment Drug Product Offered
11.8.3 Biosergen AB Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Biosergen AB Main Business Overview
11.8.5 Biosergen AB Latest Developments
11.9 Matinas BioPharma Holdings, Inc
11.9.1 Matinas BioPharma Holdings, Inc Company Information
11.9.2 Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Product Offered
11.9.3 Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Matinas BioPharma Holdings, Inc Main Business Overview
11.9.5 Matinas BioPharma Holdings, Inc Latest Developments
11.10 Pulmocide Ltd
11.10.1 Pulmocide Ltd Company Information
11.10.2 Pulmocide Ltd Invasive Candidiasis Treatment Drug Product Offered
11.10.3 Pulmocide Ltd Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Pulmocide Ltd Main Business Overview
11.10.5 Pulmocide Ltd Latest Developments
11.11 F2G Ltd
11.11.1 F2G Ltd Company Information
11.11.2 F2G Ltd Invasive Candidiasis Treatment Drug Product Offered
11.11.3 F2G Ltd Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 F2G Ltd Main Business Overview
11.11.5 F2G Ltd Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Invasive Candidiasis Treatment Drug Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Invasive Candidiasis Treatment Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Azoles Drug
Table 4. Major Players of Echinocandins Drug
Table 5. Major Players of Allylamines Drug
Table 6. Major Players of Polyenes Drug
Table 7. Major Players of Others
Table 8. Invasive Candidiasis Treatment Drug Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Invasive Candidiasis Treatment Drug Market Size by Type (2021-2026) & ($ millions)
Table 10. Global Invasive Candidiasis Treatment Drug Market Size Market Share by Type (2021-2026)
Table 11. Invasive Candidiasis Treatment Drug Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Invasive Candidiasis Treatment Drug Market Size by Application (2021-2026) & ($ millions)
Table 13. Global Invasive Candidiasis Treatment Drug Market Size Market Share by Application (2021-2026)
Table 14. Global Invasive Candidiasis Treatment Drug Revenue by Player (2021-2026) & ($ millions)
Table 15. Global Invasive Candidiasis Treatment Drug Revenue Market Share by Player (2021-2026)
Table 16. Invasive Candidiasis Treatment Drug Key Players Head office and Products Offered
Table 17. Invasive Candidiasis Treatment Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Invasive Candidiasis Treatment Drug Market Size by Region (2021-2026) & ($ millions)
Table 21. Global Invasive Candidiasis Treatment Drug Market Size Market Share by Region (2021-2026)
Table 22. Global Invasive Candidiasis Treatment Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 23. Global Invasive Candidiasis Treatment Drug Revenue Market Share by Country/Region (2021-2026)
Table 24. Americas Invasive Candidiasis Treatment Drug Market Size by Country (2021-2026) & ($ millions)
Table 25. Americas Invasive Candidiasis Treatment Drug Market Size Market Share by Country (2021-2026)
Table 26. Americas Invasive Candidiasis Treatment Drug Market Size by Type (2021-2026) & ($ millions)
Table 27. Americas Invasive Candidiasis Treatment Drug Market Size Market Share by Type (2021-2026)
Table 28. Americas Invasive Candidiasis Treatment Drug Market Size by Application (2021-2026) & ($ millions)
Table 29. Americas Invasive Candidiasis Treatment Drug Market Size Market Share by Application (2021-2026)
Table 30. APAC Invasive Candidiasis Treatment Drug Market Size by Region (2021-2026) & ($ millions)
Table 31. APAC Invasive Candidiasis Treatment Drug Market Size Market Share by Region (2021-2026)
Table 32. APAC Invasive Candidiasis Treatment Drug Market Size by Type (2021-2026) & ($ millions)
Table 33. APAC Invasive Candidiasis Treatment Drug Market Size by Application (2021-2026) & ($ millions)
Table 34. Europe Invasive Candidiasis Treatment Drug Market Size by Country (2021-2026) & ($ millions)
Table 35. Europe Invasive Candidiasis Treatment Drug Market Size Market Share by Country (2021-2026)
Table 36. Europe Invasive Candidiasis Treatment Drug Market Size by Type (2021-2026) & ($ millions)
Table 37. Europe Invasive Candidiasis Treatment Drug Market Size by Application (2021-2026) & ($ millions)
Table 38. Middle East & Africa Invasive Candidiasis Treatment Drug Market Size by Region (2021-2026) & ($ millions)
Table 39. Middle East & Africa Invasive Candidiasis Treatment Drug Market Size by Type (2021-2026) & ($ millions)
Table 40. Middle East & Africa Invasive Candidiasis Treatment Drug Market Size by Application (2021-2026) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Invasive Candidiasis Treatment Drug
Table 42. Key Market Challenges & Risks of Invasive Candidiasis Treatment Drug
Table 43. Key Industry Trends of Invasive Candidiasis Treatment Drug
Table 44. Global Invasive Candidiasis Treatment Drug Market Size Forecast by Region (2027-2032) & ($ millions)
Table 45. Global Invasive Candidiasis Treatment Drug Market Size Market Share Forecast by Region (2027-2032)
Table 46. Global Invasive Candidiasis Treatment Drug Market Size Forecast by Type (2027-2032) & ($ millions)
Table 47. Global Invasive Candidiasis Treatment Drug Market Size Forecast by Application (2027-2032) & ($ millions)
Table 48. GlaxoSmithKline Details, Company Type, Invasive Candidiasis Treatment Drug Area Served and Its Competitors
Table 49. GlaxoSmithKline Invasive Candidiasis Treatment Drug Product Offered
Table 50. GlaxoSmithKline Invasive Candidiasis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 51. GlaxoSmithKline Main Business
Table 52. GlaxoSmithKline Latest Developments
Table 53. Merck & Co., Inc Details, Company Type, Invasive Candidiasis Treatment Drug Area Served and Its Competitors
Table 54. Merck & Co., Inc Invasive Candidiasis Treatment Drug Product Offered
Table 55. Merck & Co., Inc Invasive Candidiasis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 56. Merck & Co., Inc Main Business
Table 57. Merck & Co., Inc Latest Developments
Table 58. Pfizer Inc Details, Company Type, Invasive Candidiasis Treatment Drug Area Served and Its Competitors
Table 59. Pfizer Inc Invasive Candidiasis Treatment Drug Product Offered
Table 60. Pfizer Inc Invasive Candidiasis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Pfizer Inc Main Business
Table 62. Pfizer Inc Latest Developments
Table 63. Cidara Therapeutics, Inc Details, Company Type, Invasive Candidiasis Treatment Drug Area Served and Its Competitors
Table 64. Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Product Offered
Table 65. Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Cidara Therapeutics, Inc Main Business
Table 67. Cidara Therapeutics, Inc Latest Developments
Table 68. Astellas Pharma Inc Details, Company Type, Invasive Candidiasis Treatment Drug Area Served and Its Competitors
Table 69. Astellas Pharma Inc Invasive Candidiasis Treatment Drug Product Offered
Table 70. Astellas Pharma Inc Invasive Candidiasis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Astellas Pharma Inc Main Business
Table 72. Astellas Pharma Inc Latest Developments
Table 73. Gilead Sciences, Inc Details, Company Type, Invasive Candidiasis Treatment Drug Area Served and Its Competitors
Table 74. Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Product Offered
Table 75. Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Gilead Sciences, Inc Main Business
Table 77. Gilead Sciences, Inc Latest Developments
Table 78. Novo Nordisk A/S (Xellia Pharmaceuticals) Details, Company Type, Invasive Candidiasis Treatment Drug Area Served and Its Competitors
Table 79. Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Product Offered
Table 80. Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Novo Nordisk A/S (Xellia Pharmaceuticals) Main Business
Table 82. Novo Nordisk A/S (Xellia Pharmaceuticals) Latest Developments
Table 83. Biosergen AB Details, Company Type, Invasive Candidiasis Treatment Drug Area Served and Its Competitors
Table 84. Biosergen AB Invasive Candidiasis Treatment Drug Product Offered
Table 85. Biosergen AB Invasive Candidiasis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Biosergen AB Main Business
Table 87. Biosergen AB Latest Developments
Table 88. Matinas BioPharma Holdings, Inc Details, Company Type, Invasive Candidiasis Treatment Drug Area Served and Its Competitors
Table 89. Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Product Offered
Table 90. Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Matinas BioPharma Holdings, Inc Main Business
Table 92. Matinas BioPharma Holdings, Inc Latest Developments
Table 93. Pulmocide Ltd Details, Company Type, Invasive Candidiasis Treatment Drug Area Served and Its Competitors
Table 94. Pulmocide Ltd Invasive Candidiasis Treatment Drug Product Offered
Table 95. Pulmocide Ltd Invasive Candidiasis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Pulmocide Ltd Main Business
Table 97. Pulmocide Ltd Latest Developments
Table 98. F2G Ltd Details, Company Type, Invasive Candidiasis Treatment Drug Area Served and Its Competitors
Table 99. F2G Ltd Invasive Candidiasis Treatment Drug Product Offered
Table 100. F2G Ltd Invasive Candidiasis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. F2G Ltd Main Business
Table 102. F2G Ltd Latest Developments
Table 1. Invasive Candidiasis Treatment Drug Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Invasive Candidiasis Treatment Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Azoles Drug
Table 4. Major Players of Echinocandins Drug
Table 5. Major Players of Allylamines Drug
Table 6. Major Players of Polyenes Drug
Table 7. Major Players of Others
Table 8. Invasive Candidiasis Treatment Drug Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Invasive Candidiasis Treatment Drug Market Size by Type (2021-2026) & ($ millions)
Table 10. Global Invasive Candidiasis Treatment Drug Market Size Market Share by Type (2021-2026)
Table 11. Invasive Candidiasis Treatment Drug Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Invasive Candidiasis Treatment Drug Market Size by Application (2021-2026) & ($ millions)
Table 13. Global Invasive Candidiasis Treatment Drug Market Size Market Share by Application (2021-2026)
Table 14. Global Invasive Candidiasis Treatment Drug Revenue by Player (2021-2026) & ($ millions)
Table 15. Global Invasive Candidiasis Treatment Drug Revenue Market Share by Player (2021-2026)
Table 16. Invasive Candidiasis Treatment Drug Key Players Head office and Products Offered
Table 17. Invasive Candidiasis Treatment Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Invasive Candidiasis Treatment Drug Market Size by Region (2021-2026) & ($ millions)
Table 21. Global Invasive Candidiasis Treatment Drug Market Size Market Share by Region (2021-2026)
Table 22. Global Invasive Candidiasis Treatment Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 23. Global Invasive Candidiasis Treatment Drug Revenue Market Share by Country/Region (2021-2026)
Table 24. Americas Invasive Candidiasis Treatment Drug Market Size by Country (2021-2026) & ($ millions)
Table 25. Americas Invasive Candidiasis Treatment Drug Market Size Market Share by Country (2021-2026)
Table 26. Americas Invasive Candidiasis Treatment Drug Market Size by Type (2021-2026) & ($ millions)
Table 27. Americas Invasive Candidiasis Treatment Drug Market Size Market Share by Type (2021-2026)
Table 28. Americas Invasive Candidiasis Treatment Drug Market Size by Application (2021-2026) & ($ millions)
Table 29. Americas Invasive Candidiasis Treatment Drug Market Size Market Share by Application (2021-2026)
Table 30. APAC Invasive Candidiasis Treatment Drug Market Size by Region (2021-2026) & ($ millions)
Table 31. APAC Invasive Candidiasis Treatment Drug Market Size Market Share by Region (2021-2026)
Table 32. APAC Invasive Candidiasis Treatment Drug Market Size by Type (2021-2026) & ($ millions)
Table 33. APAC Invasive Candidiasis Treatment Drug Market Size by Application (2021-2026) & ($ millions)
Table 34. Europe Invasive Candidiasis Treatment Drug Market Size by Country (2021-2026) & ($ millions)
Table 35. Europe Invasive Candidiasis Treatment Drug Market Size Market Share by Country (2021-2026)
Table 36. Europe Invasive Candidiasis Treatment Drug Market Size by Type (2021-2026) & ($ millions)
Table 37. Europe Invasive Candidiasis Treatment Drug Market Size by Application (2021-2026) & ($ millions)
Table 38. Middle East & Africa Invasive Candidiasis Treatment Drug Market Size by Region (2021-2026) & ($ millions)
Table 39. Middle East & Africa Invasive Candidiasis Treatment Drug Market Size by Type (2021-2026) & ($ millions)
Table 40. Middle East & Africa Invasive Candidiasis Treatment Drug Market Size by Application (2021-2026) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Invasive Candidiasis Treatment Drug
Table 42. Key Market Challenges & Risks of Invasive Candidiasis Treatment Drug
Table 43. Key Industry Trends of Invasive Candidiasis Treatment Drug
Table 44. Global Invasive Candidiasis Treatment Drug Market Size Forecast by Region (2027-2032) & ($ millions)
Table 45. Global Invasive Candidiasis Treatment Drug Market Size Market Share Forecast by Region (2027-2032)
Table 46. Global Invasive Candidiasis Treatment Drug Market Size Forecast by Type (2027-2032) & ($ millions)
Table 47. Global Invasive Candidiasis Treatment Drug Market Size Forecast by Application (2027-2032) & ($ millions)
Table 48. GlaxoSmithKline Details, Company Type, Invasive Candidiasis Treatment Drug Area Served and Its Competitors
Table 49. GlaxoSmithKline Invasive Candidiasis Treatment Drug Product Offered
Table 50. GlaxoSmithKline Invasive Candidiasis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 51. GlaxoSmithKline Main Business
Table 52. GlaxoSmithKline Latest Developments
Table 53. Merck & Co., Inc Details, Company Type, Invasive Candidiasis Treatment Drug Area Served and Its Competitors
Table 54. Merck & Co., Inc Invasive Candidiasis Treatment Drug Product Offered
Table 55. Merck & Co., Inc Invasive Candidiasis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 56. Merck & Co., Inc Main Business
Table 57. Merck & Co., Inc Latest Developments
Table 58. Pfizer Inc Details, Company Type, Invasive Candidiasis Treatment Drug Area Served and Its Competitors
Table 59. Pfizer Inc Invasive Candidiasis Treatment Drug Product Offered
Table 60. Pfizer Inc Invasive Candidiasis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Pfizer Inc Main Business
Table 62. Pfizer Inc Latest Developments
Table 63. Cidara Therapeutics, Inc Details, Company Type, Invasive Candidiasis Treatment Drug Area Served and Its Competitors
Table 64. Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Product Offered
Table 65. Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Cidara Therapeutics, Inc Main Business
Table 67. Cidara Therapeutics, Inc Latest Developments
Table 68. Astellas Pharma Inc Details, Company Type, Invasive Candidiasis Treatment Drug Area Served and Its Competitors
Table 69. Astellas Pharma Inc Invasive Candidiasis Treatment Drug Product Offered
Table 70. Astellas Pharma Inc Invasive Candidiasis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Astellas Pharma Inc Main Business
Table 72. Astellas Pharma Inc Latest Developments
Table 73. Gilead Sciences, Inc Details, Company Type, Invasive Candidiasis Treatment Drug Area Served and Its Competitors
Table 74. Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Product Offered
Table 75. Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Gilead Sciences, Inc Main Business
Table 77. Gilead Sciences, Inc Latest Developments
Table 78. Novo Nordisk A/S (Xellia Pharmaceuticals) Details, Company Type, Invasive Candidiasis Treatment Drug Area Served and Its Competitors
Table 79. Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Product Offered
Table 80. Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Novo Nordisk A/S (Xellia Pharmaceuticals) Main Business
Table 82. Novo Nordisk A/S (Xellia Pharmaceuticals) Latest Developments
Table 83. Biosergen AB Details, Company Type, Invasive Candidiasis Treatment Drug Area Served and Its Competitors
Table 84. Biosergen AB Invasive Candidiasis Treatment Drug Product Offered
Table 85. Biosergen AB Invasive Candidiasis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Biosergen AB Main Business
Table 87. Biosergen AB Latest Developments
Table 88. Matinas BioPharma Holdings, Inc Details, Company Type, Invasive Candidiasis Treatment Drug Area Served and Its Competitors
Table 89. Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Product Offered
Table 90. Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Matinas BioPharma Holdings, Inc Main Business
Table 92. Matinas BioPharma Holdings, Inc Latest Developments
Table 93. Pulmocide Ltd Details, Company Type, Invasive Candidiasis Treatment Drug Area Served and Its Competitors
Table 94. Pulmocide Ltd Invasive Candidiasis Treatment Drug Product Offered
Table 95. Pulmocide Ltd Invasive Candidiasis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Pulmocide Ltd Main Business
Table 97. Pulmocide Ltd Latest Developments
Table 98. F2G Ltd Details, Company Type, Invasive Candidiasis Treatment Drug Area Served and Its Competitors
Table 99. F2G Ltd Invasive Candidiasis Treatment Drug Product Offered
Table 100. F2G Ltd Invasive Candidiasis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. F2G Ltd Main Business
Table 102. F2G Ltd Latest Developments
LIST OF FIGURES
Figure 1. Invasive Candidiasis Treatment Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Invasive Candidiasis Treatment Drug Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Invasive Candidiasis Treatment Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Invasive Candidiasis Treatment Drug Sales Market Share by Country/Region (2025)
Figure 8. Invasive Candidiasis Treatment Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Invasive Candidiasis Treatment Drug Market Size Market Share by Type in 2025
Figure 10. Invasive Candidiasis Treatment Drug in Hospital
Figure 11. Global Invasive Candidiasis Treatment Drug Market: Hospital (2021-2026) & ($ millions)
Figure 12. Invasive Candidiasis Treatment Drug in Clinic
Figure 13. Global Invasive Candidiasis Treatment Drug Market: Clinic (2021-2026) & ($ millions)
Figure 14. Invasive Candidiasis Treatment Drug in Others
Figure 15. Global Invasive Candidiasis Treatment Drug Market: Others (2021-2026) & ($ millions)
Figure 16. Global Invasive Candidiasis Treatment Drug Market Size Market Share by Application in 2025
Figure 17. Global Invasive Candidiasis Treatment Drug Revenue Market Share by Player in 2025
Figure 18. Global Invasive Candidiasis Treatment Drug Market Size Market Share by Region (2021-2026)
Figure 19. Americas Invasive Candidiasis Treatment Drug Market Size 2021-2026 ($ millions)
Figure 20. APAC Invasive Candidiasis Treatment Drug Market Size 2021-2026 ($ millions)
Figure 21. Europe Invasive Candidiasis Treatment Drug Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Invasive Candidiasis Treatment Drug Market Size 2021-2026 ($ millions)
Figure 23. Americas Invasive Candidiasis Treatment Drug Value Market Share by Country in 2025
Figure 24. United States Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Invasive Candidiasis Treatment Drug Market Size Market Share by Region in 2025
Figure 29. APAC Invasive Candidiasis Treatment Drug Market Size Market Share by Type (2021-2026)
Figure 30. APAC Invasive Candidiasis Treatment Drug Market Size Market Share by Application (2021-2026)
Figure 31. China Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 35. India Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Invasive Candidiasis Treatment Drug Market Size Market Share by Country in 2025
Figure 38. Europe Invasive Candidiasis Treatment Drug Market Size Market Share by Type (2021-2026)
Figure 39. Europe Invasive Candidiasis Treatment Drug Market Size Market Share by Application (2021-2026)
Figure 40. Germany Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 41. France Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Invasive Candidiasis Treatment Drug Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Invasive Candidiasis Treatment Drug Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Invasive Candidiasis Treatment Drug Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 54. APAC Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 55. Europe Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 57. United States Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 58. Canada Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 59. Mexico Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 60. Brazil Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 61. China Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 62. Japan Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 63. Korea Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 65. India Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 66. Australia Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 67. Germany Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 68. France Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 69. UK Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 70. Italy Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 71. Russia Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 72. Egypt Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 73. South Africa Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 74. Israel Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 75. Turkey Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 76. Global Invasive Candidiasis Treatment Drug Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Invasive Candidiasis Treatment Drug Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 1. Invasive Candidiasis Treatment Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Invasive Candidiasis Treatment Drug Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Invasive Candidiasis Treatment Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Invasive Candidiasis Treatment Drug Sales Market Share by Country/Region (2025)
Figure 8. Invasive Candidiasis Treatment Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Invasive Candidiasis Treatment Drug Market Size Market Share by Type in 2025
Figure 10. Invasive Candidiasis Treatment Drug in Hospital
Figure 11. Global Invasive Candidiasis Treatment Drug Market: Hospital (2021-2026) & ($ millions)
Figure 12. Invasive Candidiasis Treatment Drug in Clinic
Figure 13. Global Invasive Candidiasis Treatment Drug Market: Clinic (2021-2026) & ($ millions)
Figure 14. Invasive Candidiasis Treatment Drug in Others
Figure 15. Global Invasive Candidiasis Treatment Drug Market: Others (2021-2026) & ($ millions)
Figure 16. Global Invasive Candidiasis Treatment Drug Market Size Market Share by Application in 2025
Figure 17. Global Invasive Candidiasis Treatment Drug Revenue Market Share by Player in 2025
Figure 18. Global Invasive Candidiasis Treatment Drug Market Size Market Share by Region (2021-2026)
Figure 19. Americas Invasive Candidiasis Treatment Drug Market Size 2021-2026 ($ millions)
Figure 20. APAC Invasive Candidiasis Treatment Drug Market Size 2021-2026 ($ millions)
Figure 21. Europe Invasive Candidiasis Treatment Drug Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Invasive Candidiasis Treatment Drug Market Size 2021-2026 ($ millions)
Figure 23. Americas Invasive Candidiasis Treatment Drug Value Market Share by Country in 2025
Figure 24. United States Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Invasive Candidiasis Treatment Drug Market Size Market Share by Region in 2025
Figure 29. APAC Invasive Candidiasis Treatment Drug Market Size Market Share by Type (2021-2026)
Figure 30. APAC Invasive Candidiasis Treatment Drug Market Size Market Share by Application (2021-2026)
Figure 31. China Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 35. India Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Invasive Candidiasis Treatment Drug Market Size Market Share by Country in 2025
Figure 38. Europe Invasive Candidiasis Treatment Drug Market Size Market Share by Type (2021-2026)
Figure 39. Europe Invasive Candidiasis Treatment Drug Market Size Market Share by Application (2021-2026)
Figure 40. Germany Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 41. France Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Invasive Candidiasis Treatment Drug Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Invasive Candidiasis Treatment Drug Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Invasive Candidiasis Treatment Drug Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Invasive Candidiasis Treatment Drug Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 54. APAC Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 55. Europe Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 57. United States Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 58. Canada Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 59. Mexico Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 60. Brazil Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 61. China Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 62. Japan Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 63. Korea Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 65. India Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 66. Australia Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 67. Germany Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 68. France Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 69. UK Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 70. Italy Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 71. Russia Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 72. Egypt Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 73. South Africa Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 74. Israel Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 75. Turkey Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
Figure 76. Global Invasive Candidiasis Treatment Drug Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Invasive Candidiasis Treatment Drug Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Invasive Candidiasis Treatment Drug Market Size 2027-2032 ($ millions)
